SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-153010
Filing Date
2015-04-28
Accepted
2015-04-28 16:31:08
Documents
3
Period of Report
2015-05-28
Effectiveness Date
2015-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d896622ddef14a.htm DEF 14A 237303
2 GRAPHIC g896622g21j21.jpg GRAPHIC 9173
3 GRAPHIC g896622g31p31.jpg GRAPHIC 9096
  Complete submission text file 0001193125-15-153010.txt   263892
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 15799019
SIC: 2834 Pharmaceutical Preparations